Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$49.38 - $63.75 $2.46 Million - $3.18 Million
-49,900 Reduced 42.87%
66,500 $4.14 Million
Q3 2023

Nov 14, 2023

BUY
$48.64 - $62.51 $3.31 Million - $4.25 Million
68,000 Added 140.5%
116,400 $6.53 Million
Q2 2023

Aug 14, 2023

BUY
$47.99 - $60.21 $2.13 Million - $2.67 Million
44,400 Added 1110.0%
48,400 $2.44 Million
Q1 2023

May 15, 2023

SELL
$52.6 - $67.34 $1.84 Million - $2.35 Million
-34,900 Reduced 89.72%
4,000 $218,000
Q4 2022

Feb 14, 2023

BUY
$59.56 - $76.6 $2.32 Million - $2.98 Million
38,900 New
38,900 $2.43 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.